Centres of Excellence
Mount Sinai's Centres of Excellence formally link departments to improve patient and family-centred care initiatives and advance our academic mandate. This model builds on the Hospital’s existing strengths and creates interprofessional groups positioned to strategically respond to changes in the health care environment.
We are pioneering a structure where clinicians and scientists work even more collaboratively to improve patient care, expedite new treatments and discoveries, and bring therapies from the research bench to the patient bedside.
Our centres include:
Frances Bloomberg Centre for Women’s and Infants’ Health
Mount Sinai Hospital has the largest, most comprehensive Women’s and Infants’ Health academic program in Canada, ranked among the top six Women’s and Infants’ Health Centres in the world.
Our Frances Bloomberg Centre of Excellence in Women’s and Infants’ health offers a continuity of care that covers the spectrum from general obstetrics to gynaecology, from high-risk obstetrics and care of the fetus and newborns, to infertility, urinary incontinence and menopause.
And, with some 6,500 babies born here annually, we are also one of the country’s busiest birthing centres.
Christopher Sharp Centre for Surgical Oncology
The core elements of our Surgical Oncology Centre of Excellence are: Sarcoma, Head and Neck, Breast, Urological and Oculoplastics. Mount Sinai Hospital is a designated provincial treatment centre for sarcoma, drawing approximately 85% of its patients from outside the Toronto Central LHIN.
We have gained an international reputation in the area of head and neck oncology, which is one of the main foci of the Joseph and Mildred Sonshine Family Centre for Head and Neck Diseases. Through the Marvelle Koffler Breast Centre, a premier facility specializing in breast health and disease, more than 33,000 women annually receive multidisciplinary care.
The Daryl A. Katz Centre for Urgent and Critical Care
This Centre includes the Hospital’s core inpatient and ambulatory care programs, including Diabetes, General Internal Medicine, Critical Care/Respiratory Failure and Cardiology. A major thrust of this Centre will be to provide innovative and comprehensive care to manage the increasingly complex and chronic needs of elderly patients.
This program, with its highly regarded teachers and clinician-scientists, will continue to carry out a significant proportion of the Hospital’s undergraduate training. Its focus will encompass the full cycle of care by employing the skills and resources of its ambulatory and primary care programs including the Schwartz/Reisman Emergency Centre as well as those of its partners.
The Centre for Inflammatory Bowel Disease
The Centre, with its evidence-based care and leading edge research, is unique in the corrective procedures it provides. It serves a significant portion of the market, with over 60% of its referrals coming from outside the Toronto Central LHIN.
The Centre has a leadership position in the Familial Gastrointestinal Cancer registry and the Ontario Registry for Studies of Familial Colorectal Cancer and is recognized internationally for its Colorectal Fellowship Program. Our focus in this area is consistent with our clinical strengths and supports the government’s colorectal cancer prevention strategy.
Centre for Musculoskeletal Disease
Similar to Inflammatory Bowel Disease, the musculoskeletal program is unique in the corrective procedures it provides.
To serve its patients better, Mount Sinai will expand its focus on bone and musculoskeletal research, chronic diseases (e.g., arthritis, rheumatology) and health and wellness programs. Further growth is expected in this program, particularly in the area of knee and cartilage transplants due to the growing needs of the aging demographic.
Samuel Lunenfeld Research Institute
The Samuel Lunenfeld Research Institute (Lunenfeld) of Mount Sinai Hospital is one of the world’s leading centres in biomedical research and is committed to excellence in discovery, translation and application of health research.
The Lunenfeld has a strong portfolio of leading edge scientific programs that include systems biology, women’s and infants’ health, cancer biology, neurobiology, diabetes, arthritis and genetic disorders. Its researchers work collaboratively with physicians and clinicians to foster the cross-pollination of ideas and concepts that are key factors to bringing research discoveries to the patient’s bedside.
